Insights

Innovative Gene Therapy Focus Flash Therapeutics specialized in designing and bioproducing lentiviral vectors for gene, cell, RNA, and vaccine therapies, indicating a strong expertise in cutting-edge genetic medicine which could be attractive for partners seeking advanced gene therapy solutions.

Recent Leadership Appointments The appointment of Jérôme Bédier as President in mid-2023 signals a strategic leadership move that may open new business opportunities and partnerships aligned with their innovative pipeline and bioproduction capabilities.

Upcoming Clinical Production The plan to produce the first clinical batch of LentiFlash messenger RNA by the end of 2022 demonstrates immediate market readiness for RNA-based therapies, which could be relevant for biotech companies expanding into RNA therapeutics.

Funding and Investment With a recent funding round of 18 million dollars and notable private equity backing, there is significant potential for collaborations, joint ventures, or investment in advancing their bioproduction technologies and expanding their customer base.

Growth Potential Despite Liquidation Although the company is now liquidated, its technological advancements, ongoing development projects, and active partnerships present multiple opportunities for potential buyers or collaborators to integrate innovative biotech solutions into their portfolios.

Flash BioSolutions Tech Stack

Flash BioSolutions uses 8 technology products and services including Linkedin Insight Tag, jQuery, HubSpot, and more. Explore Flash BioSolutions's tech stack below.

  • Linkedin Insight Tag
    Analytics
  • jQuery
    Javascript Libraries
  • HubSpot
    Marketing Automation
  • PWA
    Miscellaneous
  • Priority Hints
    Performance
  • PHP
    Programming Languages
  • Yoast SEO
    Search Engines
  • Autoptimize
    Web Platform Extensions

Media & News

Flash BioSolutions's Email Address Formats

Flash BioSolutions uses at least 1 format(s):
Flash BioSolutions Email FormatsExamplePercentage
First.Last@flashtherapeutics.comJohn.Doe@flashtherapeutics.com
50%
First.Last@flashtherapeutics.comJohn.Doe@flashtherapeutics.com
50%

Frequently Asked Questions

What is Flash BioSolutions's official website and social media links?

Minus sign iconPlus sign icon
Flash BioSolutions's official website is flashtherapeutics.com and has social profiles on LinkedInCrunchbase.

What is Flash BioSolutions's NAICS code?

Minus sign iconPlus sign icon
Flash BioSolutions's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Flash BioSolutions have currently?

Minus sign iconPlus sign icon
As of December 2025, Flash BioSolutions has approximately 18 employees across 1 continents, including Europe. Key team members include Business & Marketing Director: A. D.Biosafety Officer & Cmc Lead: L. L.Cell Engineering Project Manager: F. S.. Explore Flash BioSolutions's employee directory with LeadIQ.

What industry does Flash BioSolutions belong to?

Minus sign iconPlus sign icon
Flash BioSolutions operates in the Pharmaceutical Manufacturing industry.

What technology does Flash BioSolutions use?

Minus sign iconPlus sign icon
Flash BioSolutions's tech stack includes Linkedin Insight TagjQueryHubSpotPWAPriority HintsPHPYoast SEOAutoptimize.

What is Flash BioSolutions's email format?

Minus sign iconPlus sign icon
Flash BioSolutions's email format typically follows the pattern of First.Last@flashtherapeutics.com. Find more Flash BioSolutions email formats with LeadIQ.

How much funding has Flash BioSolutions raised to date?

Minus sign iconPlus sign icon
As of December 2025, Flash BioSolutions has raised $18M in funding. The last funding round occurred on Aug 07, 2021 for $18M.

When was Flash BioSolutions founded?

Minus sign iconPlus sign icon
Flash BioSolutions was founded in 2005.

Flash BioSolutions

Pharmaceutical ManufacturingOccitanie, France11-50 Employees

It is with deep regret that we announce the liquidation of FlashTherapeutics and the end of its activities.
Over the years, FlashTherapeutics has been driven by the ambition to innovate and bring transformative solutions to patients. This journey would not have been possible without the dedication of our talented team, the trust of our partners and clients, and the unwavering support from all those who believed in our mission.
We want to warmly thank all employees, collaborators, and stakeholders who contributed to this adventure. Your commitment, creativity, and passion have left a lasting mark.
Although FlashTherapeutics’ path comes to an end, we are confident that the science, partnerships, and expertise that emerged along the way will continue to live on through those who pursue innovation and progress in the service of patients.
We remain proud of our collective achievements and humbled by the privilege of having contributed, even in part, to the advancement of healthcare solutions.
To everyone who walked with us on this journey: thank you.

Section iconCompany Overview

NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2005
Employees
11-50

Section iconFunding & Financials

  • $18M

    Flash BioSolutions has raised a total of $18M of funding over 2 rounds. Their latest funding round was raised on Aug 07, 2021 in the amount of $18M.

  • $1M

    Flash BioSolutions's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $18M

    Flash BioSolutions has raised a total of $18M of funding over 2 rounds. Their latest funding round was raised on Aug 07, 2021 in the amount of $18M.

  • $1M

    Flash BioSolutions's revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.